A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)

Clinical trial NCT06530251 · RECRUITING

Trial details

NCT number: NCT06530251
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2024-09-24
Primary completion: 2026-06-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.